BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Chen H, Jiao X, Wu L, Yang Y, Zhang J, Wu L, Liu C, Zhuo N, Li S, Gong J, Li J, Zhang X, Wang X, Peng Z, Qi C, Wang Z, Li J, Li Y, Lu Z, Zhang H, Shen L. PTCH1 mutation promotes antitumor immunity and the response to immune checkpoint inhibitors in colorectal cancer patients. Cancer Immunol Immunother 2021. [PMID: 34028566 DOI: 10.1007/s00262-021-02966-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Giammona A, Crivaro E, Stecca B. Emerging Roles of Hedgehog Signaling in Cancer Immunity. Int J Mol Sci 2023;24:1321. [PMID: 36674836 DOI: 10.3390/ijms24021321] [Reference Citation Analysis]
2 Ruolan Xia, Maosen Xu, Jing Yang, Xuelei Ma. The role of Hedgehog and Notch signaling pathway in cancer. Mol Biomed 2022;3:44. [PMID: 36517618 DOI: 10.1186/s43556-022-00099-8] [Reference Citation Analysis]
3 Dong P, Zhang X, Peng Y, Zhang Y, Liu R, Li Y, Pan Q, Wei W, Guo S, Zhang Z, Han H, Zhou F, Liu Y, He L. Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma. Clin Cancer Res 2022;28:4807-19. [PMID: 36074152 DOI: 10.1158/1078-0432.CCR-22-1279] [Reference Citation Analysis]
4 Liu M, Xia S, Zhang X, Zhang B, Yan L, Yang M, Ren Y, Guo H, Zhao J. Development and validation of a blood-based genomic mutation signature to predict the clinical outcomes of atezolizumab therapy in NSCLC. Lung Cancer 2022;170:148-55. [DOI: 10.1016/j.lungcan.2022.06.016] [Reference Citation Analysis]